1. Role of CD155/TIGIT in Digestive Cancers: Promising Cancer Target for Immunotherapy
   Daijun Wang et al, 2022, Frontiers in Oncology CrossRef
2. Peptide-based PET imaging agent of tumor TIGIT expression
   Dinghu Weng et al, 2023, EJNMMI Research CrossRef
3. Immune-Based Combination Therapies for Advanced Hepatocellular Carcinoma
   Riccardo Carloni et al, 2023, Journal of Hepatocellular Carcinoma CrossRef
4. Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancer
   Neslihan Cabioglu et al, 2023, Frontiers in Oncology CrossRef
5. Integrated bioinformatic analysis and cell line experiments reveal the significant role of the novel immune checkpoint TIGIT in kidney renal clear cell carcinoma
   Qi-Dong Xia et al, 2023, Frontiers in Oncology CrossRef
6. A novel scoring system for TIGIT expression in classic Hodgkin lymphoma
   Ombretta Annibali et al, 2021, Scientific Reports CrossRef
7. TIGIT signaling and its influence on T cell metabolism and immune cell function in the tumor microenvironment
   Nouria Jantz-Naeem et al, 2023, Frontiers in Oncology CrossRef
8. Prognostic Role of TIGIT Expression in Patients with Solid Tumors: A Meta-Analysis
   Kunmin Xiao et al, 2021, Journal of Immunology Research CrossRef
9. Aberrant expression of junctional adhesion molecule‐A contributes to the malignancy of cervical adenocarcinoma by interaction with poliovirus receptor/CD155
   Taro Murakami et al, 2021, Cancer Science CrossRef
10. Hitting the complexity of the TIGIT-CD96-CD112R-CD226 axis for next-generation cancer immunotherapy
    Hyung-seung Jin et al, 2021, BMB Reports CrossRef